VivoSeq
Psychiatry

Severe Alcohol Use Disorder

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Severe Alcohol Use Disorder is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

1

clinical trials

Recruiting1 · 100%

Trial Activity

Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
Recruiting··Phase 2·NCT06160232·62 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)